Arecor Therapeutics plc (AREC) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Arecor subsidiary Tetris launching Ogluo in the Netherlands
29 February 2024 14:12
(Sharecast News) - Arecor Therapeutics updated the market on an announcement made by its subsidiary Tetris Pharma on Thursday, regarding the launch of the 'Ogluo' glucagon prefilled autoinjector...
-
Arecor appoints new commercial manager to Tetris subsidiary
3 January 2024 13:44
(Sharecast News) - Arecor Therapeutics announced the appointment of Dr Helen Parris as senior vice president and commercial and general manager of its subsidiary Tetris Pharma on Wednesday.
-
Arecor inks co-development deal with global medicine company
4 December 2023 09:49
(Sharecast News) - Arecor Therapeutics announced a co-development and exclusive licence option agreement with an unnamed global medical products company on Monday.
-
Arecor gets milestone payment from Arestat partner
17 November 2023 12:06
(Sharecast News) - Arecor Therapeutics announced a significant milestone in its collaboration with a global pharmaceutical partner on Friday.
-
Arecor inks partnership with unnamed pharma giant
17 August 2023 15:55
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics has entered into a partnership agreement with an unnamed global top-10 pharmaceutical company, it announced on Thursday.
-
Arecor Therapeutics appoints new chief business officer
5 April 2023 14:07
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced the appointment of Dr Manjit Rahelu as its chief business officer on Wednesday.
-
Arecor Therapeutics begins type-2 diabetes trial
22 March 2023 17:01
(Sharecast News) - Arecor Therapeutics announced the start of the phase one clinical trial for its ultra-rapid acting insulin candidate 'AT278' on Wednesday, with the first patient being dosed.
-
Arecor granted three patents in US, India
16 February 2023 18:11
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics has received patents for its novel formulations of insulin and adalimumab, it announced on Thursday.
-
Arecor ends 2022 in line with forecasts
19 January 2023 16:05
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics said in an update on Thursday that its financial performance for 2022 was in line with market expectations, as it closed the period with an...
-
Arecor's Tetris launches 'Ogluo' in Austria
4 January 2023 16:01
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Wednesday that its subsidiary Tetris Pharma has launched 'Ogluo', or glucagon prefilled autoinjector pens, as a...
-
Arecor inks formulation study deal with 'leading' pharma firm
10 November 2022 14:01
(Sharecast News) - Biopharmaceuticals developer Arecor Therapeutics has signed an exclusive formulation study collaboration with the pharmaceutical division of "one of the world's largest"...
-
Arecor's Tetris launches hypoglycaemia treatment in Germany
1 November 2022 16:41
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Tuesday that its subsidiary Tetris Pharma has launched the 'Ogluo' glucagon-prefilled autoinjector pen as a treatment...
Company announcements Announcements
-
Arecor and TRx Biosciences research collaboration
12 March 2024 08:58
Arecor Therapeutics
-
Arecor announces launch of Ogluo® in Netherlands
29 February 2024 07:00
Arecor Therapeutics
-
Year End Trading Update
1 February 2024 07:00
Arecor Therapeutics
-
Arecor announces update on INBRX-101
23 January 2024 16:58
Arecor Therapeutics
-
Arecor granted key European patent
18 January 2024 07:00
Arecor Therapeutics
-
Expansion of specialty hospital collaboration
8 January 2024 07:00
Arecor Therapeutics
-
Appointment of SVP for Tetris Pharma Ltd
3 January 2024 07:00
Arecor Therapeutics
-
Agreement with global medical products company
4 December 2023 07:00
Arecor Therapeutics
-
Arecor Continues Collaboration with Lilly
29 November 2023 07:00
Arecor Therapeutics
-
Product with Arestat technology launched in Europe
17 November 2023 07:00
Arecor Therapeutics
-
Inhibrx milestone triggers payment to Arecor
2 November 2023 07:00
Arecor Therapeutics
-
Exercise of rollover options & Total Voting Rights
1 November 2023 15:31
Arecor Therapeutics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.